Hepatitis C clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
Sorry, not yet accepting patients
This is a Phase I/II, multi-site, open-label, single arm study to describe the pharmacokinetics (PK) and safety of glecaprevir/pibrentasvir (GLE/PIB) initiated during pregnancy in women with hepatitis C virus (HCV) infection (acute or chronic) with or without HIV and to evaluate safety for their infants through 10 weeks postpartum.
Los Angeles 5368361, California 5332921 and other locations
Last updated: